Sanofi Bond Issue Pricing

Sanofi has successfully priced an offering of €2.3 billion in notes across three tranches: €1,000 million due May 2029 at 3.000% interest, €650 million due May 2033 at 3.375% interest, and €650 million due May 2037 at 3.750% interest. These notes were issued under Sanofi’s Euro Medium Term Note programme and the net proceeds will be used for general corporate purposes. The transaction was led by Citigroup, HSBC, and J.P. Morgan as global coordinators, with Credit Agricole CIB, Deutsche Bank, RBC Capital Markets, and Unicredit as joint lead managers. Sanofi is an R&D-driven, AI-powered biopharma company focused on improving lives through medicines and vaccines.